Altea Research Institute

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials
• Mild cognitive impairment2 trials
• Depression1 trial
• Insomnia1 trial
• Schizophrenia1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Completed5 trials

Lead sponsor

• Novo Nordisk A/S2 trials
• Janssen Research & Development, LLC1 trial
• Jazz Pharmaceuticals1 trial
• Karuna Therapeutics, Inc., a Bristol Myers Squibb company1 trial

Closed trials

• Completed

  A Study of JZP150 in Adults With Posttraumatic Stress Disorder

  NCT05178316· Phase 2· Jazz Pharmaceuticals· Source

• Completed

  An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)

  NCT04820309· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

  NCT04533529· Phase 3· Janssen Research & Development, LLC· Source